Lucky to have Misha Beltran giving the Keynote address UCSD Health Moores Cancer Center COE ⚡️ Sparkathon! Rana McKay, MD, FASCO

What is your preferred brand for a treadmill? Don't be a punk and say "the outdoors". I'm looking at you Tyler Seibert MD PhD

DrBagrodia timely updates on #testicular #germcell tumors: RPLND in early stage seminoma and the promise of circulating miRNA as a predictor of path & pre-orchiectomy diagnosis as well as indicator of #MRD after surgery at the inaugural SCGCRC Forum OncoAlert

Prostate Cancer Gurus - what chemo regimens do you consider in elderly populations with mCRPC? Thoughts on cabazitaxel 16 mg/m2 every other week? JAMA Oncology Rana McKay, MD, FASCO Tanya Dorff Sumanta K. Pal, MD, FASCO Jun Gong Alan H Bryce Alicia Morgans, MD, MPH Misha Beltran jamanetwork.com/journals/jamao…

MODERN is open! Available at your site through the CRSU. Please help advance MRD-based adjuvant decision making in bladder cancer. Alliance for Clinical Trials in Oncology Alan Tan Ashish M. Kamat, MD, MBBS ECOG-ACRIN Cancer Research Group SWOG Cancer Research Network Guru P. Sonpavde, MD PaulCrispenMD Stephanie Berg Suzanne Cole, MD, FACP, FASCO Nitin Yerram M.D. DrTylerStewart Jonathan Rosenberg MD

🧠 Find out the thoughts of Alexander Wyatt, BSc, DPhil, of University of British Columbia, and DrTylerStewart of UC San Diego, on the progress of #LiquidBiopsies for patients with #GUCancers. 📚 Read More: buff.ly/3wireLl

MASSIVE ⁦Bladder Cancer Advocacy Network⁩ Walk ⁦UC San Diego Health Moores Cancer Center⁩ headlined by The Adverse Events! Wonderful patient & caregiver turnout! ⁦UCSD Urology⁩ Tumor Terminators showed up in droves! ⁦DrTylerStewart⁩ ⁦Amir Salmasi⁩ ⁦UC San Diego Health⁩ ⁦UCSD Health Moores Cancer Center COE⁩

No one walks alone. To our patients and their families always. we will strive to do better and for the day we no longer need to have these walks! DrBagrodia DrTylerStewart #BCAN Amir Salmasi UCSD Urology #brentrose Awesome performance jamming out with the The Adverse Events

1/2 ctDNA results of chemo vs pembro in 1st line mUC(KN361) #ASCO24. 90% of patients are ctDNA +ve. Better outcomes for pembro occur with lower ctDNA baseline levels. ctDNA clearance occurs in chemo=41%, pembro=11%. But reductions more clinically meaningful with pembrolizumab.

Please check out poster 280 by DrTylerStewart investigating NECTIN 4 RNA expression as potential biomarker in UC DrBagrodia Rana McKay, MD, FASCO UC San Diego Health Moores Cancer Center #ASCO24

Please check out the ARCITECT study lead by Michael Serzan, MD, Dr. Michael Atkins studying novel IO combo (botensilimab/balstilimab). We have this trial opened at UC San Diego Health Moores Cancer Center #ASCO24 Rana McKay, MD, FASCO

@asco plenary time for #nsclc medical oncology

Final results of #CORE001 trial out now Nature Medicine (1/14) 35 pts with BCG-UR CIS treated w/ Creto + pembro 👉12mo CR (per RBB) = 57.1% (ITT) 👉24mo CR = 54% *(Auth Corr) 👉No patient progressed to MIBC 👉No synergistic toxicity Gary Steinberg nature.com/articles/s4159…

Phenomenal day at Bladder Cancer Advocacy Network #BCANTT24 with many friends/colleagues! Impressive performance by DrTylerStewart & his band! Shilpa Gupta Eugene Pietzak Omar Mian @BhatiaS_MD Dr. Bishoy M. Faltas Parminder singh Karine Tawagi MD Alan Tan Vadim Koshkin MD Sarah P. Psutka MD MS Thomas Flaig Stephanie Chisolm, PhD

Thanks Bladder Cancer Advocacy Network and Stephanie Chisolm, PhD for letting the The Adverse Events perform at #TT24. Honor and privilege to participate and support this amazing organization and conference. Thanks Petros Grivas for capturing a bit of it. 🎸 🤘

Live music is better when it is played by a band of MCC oncologists. 👏 “Adverse Events” band members Dr. Soo Park, Dr. Greg Daniels, DrTylerStewart, & Dr. Fred Millard take the stage at the #MCCAnnualScientificRetreat. 🎶

DrTylerStewart gives breadth of updates in #bladdercancer in 15mins. Covers metastatic, adjuvant, MIBC, and NMIBC — great start to GU session moderated by Yu-Wei Chen, MD, MS UC San Diego Health Moores Cancer Center #UCSDoncology2024

Ezra Cohen Tempus and Dr #RichardSchwab Genentech discuss academic to industry transitions. Interesting take on push and take on careers making a difference for our patients and across society. UC San Diego Health Moores Cancer Center #UCSDOncology2024

📢 New series! Introducing the MODERN Trial: using cDNA testing to guide immunotherapy for #BladderCancer post-surgery, detecting recurrence early, and tailoring treatment to improve outcomes. Watch: primrmed.com/cancer-clinica… @MattGalsky Stephanie Berg Alliance for Clinical Trials in Oncology Natera Oncology

Will be on X for 5 days for #ESMO25 updates. Let’s see if this thing is less crazy.